RSS   Newsletter   Contact   Advertise with us

Advanced Oncotherapy appoints Euan Thomson as director

Staff writer | London, United Kingdom | February 24, 2014
Euan ThomsonFebruary 24, 2014, London, United Kingdom - Advanced Oncotherapy, a developer of medical technology for cancer treatment, announced the appointment of Euan Thomson as a non-executive director.
Mr. Thomson is a scientist and business professional and is currently an Operating Partner at venture capital firm Khosla Ventures (Menlo Park, California) where he is guiding companies in the new and emerging field of mobile and digital health. He has played pioneering roles with a series of breakthrough technologies in his career, with more than 14 years of experience as a CEO managing both private and public companies prior to joining Khosla Ventures.

Trained as a physicist at the University of London, Mr. Thomson devoted more than 15 years to research, teaching, clinical practice, and administration within the United Kingdom healthcare system. He formed a consultancy practice, providing advice for companies and hospitals on scientific development, product marketing, and management. Serving clients such as Varian Medical Systems and Radionics, he specialised in development, positioning, regulatory approvals, pricing and reimbursement of U.S. products for international markets.

In 2002, Mr. Thomson joined Accuray Inc., a small, privately-held company. He secured worldwide clinical acceptance for CyberKnife Radiosurgery through the creation of protocols and studies for the treatment of tumours in the brain, spine, lung, liver, pancreas, prostate and breast. He improved Accuray's intellectual property portfolio from 5 issued patents to 290. He built distribution channels in more than 80 countries; he executed a strategic sales alliance with Siemens Healthcare and consummated the successful acquisition of TomoTherapy.

Both at Accuray and his prior company, Photoelectron, Mr. Thomson initiated and directed a host of sophisticated financial transactions including private and public investments and Initial Public Offerings.

Mr. Thomson is Chair of the Board of Directors of the Hospice of the Valley. He has served as Chair of the California Division of the American Cancer Society's CEO's Against Cancer. He is the recipient of an Ernst and Young Entrepreneur of the Year award (N. California, Health & Life Sciences), and an ABBY Award from the Adaptive Business Leaders Organisation for his innovation in biotechnology.

Mr. Thomson earned a B.S. in Physics, an M.S. in Radiation Physics, and a Ph.D. in Physics and is the author of numerous scientific papers and holds six U.S. patents.


 LATEST MOVES FROM United Kingdom 


MORE INSIDE POST